Advertisement
Advertisement
U.S. markets open in 5 hours 28 minutes
Advertisement
Advertisement
Advertisement
Advertisement

GH Research PLC (GHRS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.00-3.80 (-24.05%)
At close: 04:00PM EDT
12.97 +0.97 (+8.08%)
After hours: 04:49PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close15.80
Open16.32
Bid0.00 x 1300
Ask0.00 x 2200
Day's Range11.99 - 17.41
52 Week Range8.72 - 30.43
Volume40,516
Avg. Volume86,127
Market Cap624.25M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.28
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est46.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for GHRS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GH Research PLC
    Daily – Vickers Top Buyers & Sellers for 09/28/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more
  • GlobeNewswire

    GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

    DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the first quarter ended March 31, 2022 and gave updates on its business. First Quarter 2022 Financial Highlights Cash position Cash was $270.8 million as of March 31, 2022, compared to $276.8 million as of December 31, 2021. We believe that our existing c

  • GlobeNewswire

    GH Research Reports Full Year 2021 Financial Results and Provides Business Updates

    DUBLIN, Ireland., March 28, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the full year ended December 31, 2021 and gave updates on its business. Fourth Quarter 2021 Business Highlights In December 2021, we reported the successful outcome of the Phase 2 part of our Phase 1/2 clinical trial of GH001, our proprietary inhalable

  • Simply Wall St.

    We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Advertisement
Advertisement